231 related articles for article (PubMed ID: 22089813)
1. Early migration of an Amplatzer muscular ventricular septal defect occluder device causing severe tricuspid valve obstruction.
Panduranga P; Al-Farqani A; Al-Maskari S
J Cardiovasc Med (Hagerstown); 2012 May; 13(5):336-7. PubMed ID: 22089813
[TBL] [Abstract][Full Text] [Related]
2. Very Late Dislocation of an AMPLATZER Septal Occluder Device Suspected Thanks to a Recent Onset of Right-Axis Deviation.
Dendramis G; Paleologo C; Piraino D; Augugliaro S
JACC Cardiovasc Interv; 2016 Apr; 9(8):859-860. PubMed ID: 27101912
[No Abstract] [Full Text] [Related]
3. Dislocation of an Amplatzer device occluder 12 years following transcatheter insertion for a perimembranous ventricular septal defect.
Song L; An Q
J Card Surg; 2018 Dec; 33(12):867-869. PubMed ID: 30548083
[No Abstract] [Full Text] [Related]
4. Failed closure of a ventricular septal defect with an Amplatzer occluder.
Wippermann J; Hoppe UC; Sreeram N; Wahlers T
Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):320-1. PubMed ID: 19914923
[TBL] [Abstract][Full Text] [Related]
5. Medium to long-term echo follow-up after ventricular septal defect device closure.
Rahmath MR; Numan M; Dilawar M
Asian Cardiovasc Thorac Ann; 2016 Jun; 24(5):422-7. PubMed ID: 27112358
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
Pinto RJ; Dalvi BV; Sharma S
Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device.
Bass JL; Gruenstein D
Catheter Cardiovasc Interv; 2012 Jun; 79(7):1153-60. PubMed ID: 22162409
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Closure of Perimembranous Ventricular Septal Defect with Modified Double-disk Occluder: What Is the Outcome at 10-year Follow-up?
Bai Y; Liu J; Qin YW; Wu H; Zhao XX
Congenit Heart Dis; 2016; 11(1):45-51. PubMed ID: 26171994
[TBL] [Abstract][Full Text] [Related]
9. Embolized Amplatzer septal occluder device presenting with ventricular fibrillation.
Yuce M; Ozer O; Cakici M; Cine N; Sari I; Davutoglu V
Cardiovasc Revasc Med; 2011; 12(2):131-2. PubMed ID: 21421193
[TBL] [Abstract][Full Text] [Related]
10. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II.
Koneti NR; Penumatsa RR; Kanchi V; Arramraj SK; S J; Bhupathiraju S
Catheter Cardiovasc Interv; 2011 Feb; 77(2):252-9. PubMed ID: 20578168
[TBL] [Abstract][Full Text] [Related]
11. Device closure of ventricular septal defects by hybrid procedures: a multicenter retrospective study.
Michel-Behnke I; Ewert P; Koch A; Bertram H; Emmel M; Fischer G; Gitter R; Kozlik-Feldman R; Motz R; Kitzmüller E; Kretschmar O;
Catheter Cardiovasc Interv; 2011 Feb; 77(2):242-51. PubMed ID: 20517999
[TBL] [Abstract][Full Text] [Related]
12. Late dislocation of an Amplatzer septal occluder in the chordae tendineae of the tricuspid valve after failed transcatheter closure of atrial septal defect.
Artemiou P; Bezák B; Hulman M
Hellenic J Cardiol; 2019; 60(3):205-206. PubMed ID: 30063983
[No Abstract] [Full Text] [Related]
13. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block?
Bentham JR; Gujral A; Adwani S; Archer N; Wilson N
Cardiol Young; 2011 Jun; 21(3):271-80. PubMed ID: 21281545
[TBL] [Abstract][Full Text] [Related]
14. [Classification of congenital ventricular defects using echocardiography for transcatheter closure].
Lai YQ; Huang XS
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):323-5. PubMed ID: 19246313
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.
Velasco-Sanchez D; Tzikas A; Ibrahim R; Miró J
Catheter Cardiovasc Interv; 2013 Sep; 82(3):474-9. PubMed ID: 22431366
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
Zhao PJ; Yu ZQ; Gao W; Li F; Fu LJ; Liu TL; Li Y; Zhang YQ; Huang MR; Guo Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):817-20. PubMed ID: 23302666
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous ventricular septal defect closure with Amplatzer devices resulting in severe tricuspid regurgitation.
Matyal R; Wang A; Mahmood F
Catheter Cardiovasc Interv; 2013 Nov; 82(6):E817-20. PubMed ID: 23553968
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter Closure of Perimembranous Ventricular Septal Defects With Amplatzer Duct Occluders.
Lin MT; Chen CA; Hsu JY; Lin HC; Chiu SN; Lin SM; Chang YM; Lu CW; Wu MH; Wang JK
JACC Cardiovasc Interv; 2017 Nov; 10(21):2227-2228. PubMed ID: 29122136
[No Abstract] [Full Text] [Related]
19. Severe aortic valve regurgitation after percutaneous ventricular septal defect closure.
Fouilloux V; Kreitmann B
Catheter Cardiovasc Interv; 2012 Nov; 80(6):944-5. PubMed ID: 22431277
[TBL] [Abstract][Full Text] [Related]
20. The role of echocardiography in the management of an embolized atrial septal Helex occluder.
Almeida-Chen G; Niezgoda J; Diaz-Gomez JL; Motta P
Anesth Analg; 2010 Mar; 110(3):734-6; discussion 736. PubMed ID: 20042445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
